Alkermes
Alkermes is a provider of innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global biopharmaceutical company, Alkermes applies its scientific expertise, proprietary technologies, and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.
Financial Data
-
31st Dec 19 Source: CRO
- €645.4 million turnover
-
€138.8 million
profit - 361 employees
-
31st Dec 18 Source: CRO
- €662.9 million turnover
-
-€145.7 million
profit - 361 employees
- 7 more years available »
Ranking
By Turnover
(€645.4 million)- 133rd in Top Companies
- 19th in Health
- 18th in Pharma
By Employees
(361)- 453rd in Top Companies
- 67th in Health
- 46th in Pharma
-
- 361
- €645.4 million
Employees
- Richard Pops CEO/Managing Director
Latest News
- 5:00am Davy locks local rival Cantor Fitzgerald out of sale process
- 4:58am OECD tax chief says Ireland will need to decide on sensitive issue of 12.5% tax rate
- Apr 16 Aer Lingus faces further cost cuts if summer revenues are lost, chief says
- Apr 16 Carphone Warehouse considers closing its stores in Ireland
- Apr 16 European stocks notch new highs as Daimler earnings lift car makers